Biocare’s strong growth in immunohistochemistry is expected to strengthen Agilent’s ability to develop new in vitro diagnostic antibodies.

MiniMed, Medtronic’s diabetes tech spinoff, made its debut on the public markets Friday. The company started trading on the ...

Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device ...

The robotics company, which has taken steps to preserve cash amid the latest change of course in the development of its ...

Medtronic on Tuesday priced a planned initial public offering for its MiniMed diabetes spinoff at up to $784 million. MiniMed ...

Labcorp’s pathologists will use the software to review, interpret and manage digital images of slides for primary diagnosis.

The Court of International Trade on Wednesday directed Customs and Border Protection to remove defunct tariffs when finalizing non-liquidated entries.

The Dexcom CEO will lead the lobbying group’s sector representing diabetes tech companies around the world.

CEO Massimiliano Colella delayed introducing the company’s soft tissue surgery system in the U.S. by a year but says the improved robot that is hitting the market now was worth the wait.

Quantum, developer of the Epione robotic platform for cancer treatment, said the acquisition supports its strategy of ...

UFP Technologies, a Massachusetts-based medical device maker, said it is investigating a cyberattack in mid-February that led to some of its company data being stolen or potentially destroyed, ...

Buying Gleamer will expand the capabilities RadNet acquired through the DeepHealth buyout in 2020, particularly in X-ray, and ...